Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Grant revenue	$ 333,351	$ 28,004	$ 384,780	$ 95,439
Operating expenses:
Research and development	2,681,898	5,102,090	6,700,557	10,339,514
General and administrative	2,670,363	3,678,119	5,789,579	6,891,317
Total operating expenses	5,352,261	8,780,209	12,490,136	17,230,831
Loss from operations	(5,018,910)	(8,752,205)	(12,105,356)	(17,135,392)
Other income (expense):
Interest income	36,120	5,880	71,199	13,065
Change in fair value of note receivable	(37,416)		(37,416)
Total other income (expense), net	(1,296)	5,880	33,783	13,065
Net loss	$ (5,020,206)	$ (8,746,325)	$ (12,071,573)	$ (17,122,327)
Net loss per share, basic (in Dollars per share)	$ (0.14)	$ (0.34)	$ (0.33)	$ (0.67)
Weighted average common shares outstanding, basic (in Shares)	36,193,085	25,373,706	36,193,085	25,372,749
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Net loss	$ (5,020,206)	$ (8,746,325)	$ (12,071,573)	$ (17,122,327)
Other comprehensive loss:
Foreign currency translation adjustments	(7,566)	(105,434)	(26,235)	(58,200)
Comprehensive loss	$ (5,027,772)	$ (8,851,759)	$ (12,097,808)	$ (17,180,527)